Multifunctional liposomes having target specificity, temperature-triggered release, and near-infrared fluorescence imaging for tumor-specific chemotherapy

Journal of Controlled Release

Volumn 216, Issue , 2015, Pages 69-77

  Kono, Kenji ^a   Takashima, Munenobu ^a   Yuba, Eiji ^a   Harada, Atsushi ^a   Hiramatsu, Yoshie ^b   Kitagawa, Hiroyuki ^b   Otani, Takayuki ^b   Maruyama, Kazuo ^c   Aoshima, Sadahito ^d  

^a Osaka Prefecture University   (Japan)

^b RandD Center Katayama Chemical Industries Co LTD ^*  (Japan)

^c TEIKYO UNIVERSITY   (Japan)

^d OSAKA UNIVERSITY   (Japan)

Author keywords

Antibody; Chemotherapy; Doxorubicin; Drug delivery; Liposome; Temperature sensitive

Indexed keywords

ANTIBODIES; CHEMOTHERAPY; DRUG DELIVERY; FLUORESCENCE; INFRARED DEVICES; MAMMALS; MONOCLONAL ANTIBODIES; TUMORS;

CONJUGATED LIPOSOMES; DOXORUBICIN; HUMAN EPIDERMAL GROWTH FACTOR; LOWER CRITICAL SOLUTION TEMPERATURE; NEAR-INFRARED FLUORESCENCE IMAGING; PHYSIOLOGICAL TEMPERATURE; TEMPERATURE SENSITIVE; TRIGGERED DRUG RELEASE;

LIPOSOMES;

COPOLYMER; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GAMMA UROGASTRONE; INDOCYANINE GREEN; LIPOSOME; POLYETHER DERIVATIVE; POLY[2 (2 ETHOXY)ETHOXYETHYLVINYLETHER]; TRASTUZUMAB; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; DELAYED RELEASE FORMULATION; ERBB2 PROTEIN, HUMAN; MACROGOL DERIVATIVE; PHOSPHATIDYLCHOLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DRUG CONJUGATION; DRUG CYTOTOXICITY; DRUG RELEASE; DRUG SPECIFICITY; FEMALE; FLUORESCENCE IMAGING; HEAT SENSITIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTERNALIZATION; MALIGNANT NEOPLASTIC DISEASE; MOUSE; NEAR INFRARED FLUORESCENCE IMAGING; NONHUMAN; PRIORITY JOURNAL; TARGET CELL; TEMPERATURE; ZETA POTENTIAL; ANIMAL; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG DELIVERY SYSTEM; DRUG EFFECTS; ELECTROCHEMISTRY; FLUORESCENCE; GENETICS; INFRARED RADIATION; NEOPLASMS; PATHOLOGY; PROCEDURES; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; ELECTROCHEMISTRY; FEMALE; FLUORESCENCE; INFRARED RAYS; LIPOSOMES; MICE; NEOPLASMS; PHOSPHATIDYLCHOLINES; POLYETHYLENE GLYCOLS; RECEPTOR, ERBB-2; TEMPERATURE; TRASTUZUMAB;

EID: 84940211791     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2015.08.005     Document Type: Article

References (43)

1. K. Riehemann, S.W. Schneider, T.A. Luger, B. Godin, M. Ferrari, and H. Fuchs Nanomediciene-challenge and perspectives Angew. Chem. Int. Ed. 48 2009 872 897
2. S. Parveen, R. Mirsa, and S.K. Sahoo Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging Nanomed. Nanotechnol. Biol. Med. 8 2012 147 166
3. S. Sultana, M.R. Khan, M. Kumar, S. Kumar, and M. Ali Nanoparticles-mediated drug delivery approaches for cancer targeting: a review J. Drug Target. 21 2013 107 125
4. J. Fang, H. Nakamura, and H. Maeda The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect Adv. Drug Deliv. Rev. 63 2011 136 151
5. V. Torchilin Tumor delivery of macromolecular drugs based on the EPR effect Adv. Drug Deliv. Rev. 63 2011 131 135
6. F. Danhier, O. Feron, and V. Preat To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery J. Control. Release 148 2010 135 146
7. L. Brannon-Peppas, and J.O. Blanchette Nanoparticle and targeted systems for cancer therapy Adv. Drug Deliv. Rev. 64 2012 206 212
8. S. Ganta, H. Devalapally, A. Shahiwala, and M. Amiji A review of stimuli-responsive nanocarriers for drug and gene delivery J. Control. Release 126 2008 187 204
9. O.C. Farokhzad, and R. Langer Nanomedicine: developing smarter therapeutic and diagnostic modalities Adv. Drug Deliv. Rev. 58 2006 1456 1459
10. K. Ninomiya, T. Yamashita, S. Kawabata, and N. Shimizu Targeted and ultrasound-triggered drug delivery using liposomes co-modified with cancer cell-targeting aptamers and a thermosensitive polymer Ultrason. Sonochem. 21 2014 1482 1488
11. S. Chandra, G. Noronha, S. Dietrich, H. Lang, and D. Bahadur Dendrimer-magnetic nanoparticles as multiple stimuli responsive and enzymatic drug delivery vehicle J. Magn. Magn. Mater. 380 2015 7 12
12. K. Katagiri, Y. Imai, K. Koumoto, T. Kaiden, K. Kono, and S. Aoshima Magnetoresponsive on-demand release of hybrid liposomes formed with Fe3O4 nanoparticles and thermosensitive block copolymers Small 7 2011 1683 1689
13. Y. Zhong, C. Wang, R. Cheng, L. Cheng, F. Meng, Z. Liub, and Z. Zhong cRGD-Directed, NIR-responsive and robust AuNR/PEG-PCL hybrid nanoparticles for targeted chemotherapy of glioblastoma in vivo J. Control. Release 195 2014 63 71
14. K. Kono Thermosensitive polymer-modified liposomes Adv. Drug Deliv. Rev. 53 2001 307 319
15. H. Grull, and S. Langereis Hyperthermia-triggered drug delivery from temperature-sensitive liposomes using MRI-guided high intensity focused ultrasound J. Control. Release 161 2012 317 327
16. E.G. Moros, J. Penagaricano, P. Novak, W.L. Straube, and R.J. Myerson Present and future technology for simultaneous superficial thermoradiotherapy of breast cancer Int. J. Hyperth. 26 2010 699 709
17. W. Rao, Z.S. Deng, and J. Liu A review of hyperthermia combined with radiotherapy/chemotherapy on malignant tumors Crit. Rev. Biomed. Eng. 38 2010 101 116
18. T. Ta, and T.M. Porter Thermosensitive liposomes for localized delivery and triggered release of chemotherapy J. Control. Release 169 2013 112 125
19. B. Kneidl, M. Peller, G. Winter, L.H. Lindner, and M. Hossann Thermosensitive liposomal drug delivery systems: state of the art review Int. J. Nanomedicine 9 2014 4387 4398
20. D. Needham, G. Anyarambhatla, G. Kong, and M.W. Dewhirst A new temperature-sensitive liposome for use with mild hyperthermia: characterization and testing in a human tumor xenograft model Cancer Res. 60 2000 1197 1201
21. M.B. Yatvin, J.N. Weinstein, W.H. Dennis, and R. Blumenthal Design of liposomes for enhanced local release of drugs by hyperthermia Science 202 1978 1290 1293
22. L.H. Lindner, M.E. Eichhorn, H. Eibl, N. Teichert, M. Schmitt-Sody, R.D. Issels, and M. Dellian Novel temperature-sensitive liposomes with prolonged circulation time Clin. Cancer Res. 10 2004 2168 2178
23. M.S. Kim, D.W. Lee, K. Park, S.J. Park, and E.J. Choi Temperature-triggered tumor-specific delivery of anticancer agents by cRGD-conjugated thermosensitive liposomes Colloids Surf. B: Biointerfaces 116 2014 17 25
24. K. Kono, H. Hayashi, and T. Takagishi Temperature-sensitive liposomes: liposomes bearing poly(N-isopropylacrylamide) J. Control. Release 30 1994 69 75
25. K. Yoshino, A. Kadowaki, T. Takagishi, and K. Kono Temperature-sensitization of liposomes by use of N-isopropylacrylamide copolymers with varying transition endotherms Bioconjug. Chem. 15 2004 1102 1109
26. K. Kono, T. Murakami, T. Yoshida, Y. Haba, S. Kanaoka, T. Takagishi, and S. Aoshima Temperature sensitization of liposomes by use of thermosensitive block copolymers synthesized by living cationic polymerization: effect of copolymer chain length Bioconjug. Chem. 16 2005 1367 1374
27. C.D. Landon, J.Y. Park, D. Needham, and M.W. Dewhirst Nanoscale drug delivery and hyperthermia: the materials design and preclinical and clinical testing of low-temperature-sensitive liposomes used in combination with mild hyperthermia in the treatment of local cancer Open Nanomed. J. 3 2011 38 64
28. P. Pradhan, J. Giri, F. Rieken, C. Koch, O. Mykhaylyk, M. Doblinger, R. Banerjee, D. Bahadur, and C. Plank Targeted temperature sensitive magnetic liposomes for thermos-chemotherapy J. Control. Release 142 2010 108 121
29. A.H. Negussie, J.L. Miller, G. Reddy, S.K. Drake, B.J. Wood, and M.R. Dreher Synthesis and in vitro evaluation of cyclic NGR peptide targeted thermally sensitive liposome J. Control. Release 143 2010 265 273
30. C. Wang, X. Wang, T. Zhong, Y. Zhao, W.Q. Zhang, W. Ren, D. Huang, S. Zhang, Y. Guo, X. Yao, Y.Q. Tang, X. Zhang, and Q. Zhang The antitumor activity of tumor-homing peptide-modified thermosensitive liposomes containing doxorubicin on MCF-7/ADR: in vitro and in vivo Int. J. Nanomed. 10 2015 2229 2248
31. M. Kullberg, K. Mann, and J.L. Owens A two-component drug delivery system using Her-2-targeting thermosensitive liposomes J. Drug Target. 17 2009 98 107
32. Z.S. Al-Ahmady, O. Chaloin, and K. Kostarelos Monoclonal antibody-targeted, temperature-sensitive liposomes: in vivo tumor chemotherapeutics in combination with mild hyperthermia J. Control. Release 196 2014 332 343
33. B. Smith, I. Lyakhov, K. Loomis, D. Needle, U. Baxa, A. Yavlovich, J. Capala, R. Blumenthal, and A. Puri Hyperthermia-triggered intracellular delivery of anticancer agent to HER2+ cells by HER2-specific affiboby (ZHER2-GS-Cys)-conjugated thermosensitive liposomes (HER2+ affisomes) J. Control. Release 153 2011 187 194
34. K. Kono, R. Nakai, K. Morimoto, and T. Takagishi Thermosensitive polymer-modified liposomes that release contents around physiological temperature Biochim. Biophys. Acta 1416 1999 239 250
35. K. Kono, T. Ozawa, T. Yoshida, F. Ozaki, Y. Ishizaka, K. Maruyama, C. Kojima, A. Harada, and S. Aoshima Highly temperature-sensitive liposomes based on a thermosensitive block copolymer for tumor-specific chemotherapy Biomaterials 31 2010 7096 7105
36. R. Fernando, J. Downs, D. Maples, and A. Ranjan MRI-guided monitoring of thermal dose and targeted drug delivery for cancer therapy Pharm. Res. 30 2013 2709 2717
37. E. Terreno, F. Uggeri, and S. Aime Image guided therapy: advent of theranostic agents J. Control. Release 161 2012 328 337
38. K. Kono, S. Nakashima, D. Kokuryo, I. Aoki, H. Shimomoto, S. Aoshima, K. Maruyama, E. Yuba, C. Kojima, A. Harada, and Y. Ishizaka Multifunctional liposomes having temperature-triggered release and magnetic resonance imaging for tumor-specific chemotherapy Biomaterials 32 2011 1387 1395
39. G.P. Adams, and L.M. Weiner Monoclonal antibody therapy of cancer Nat. Biotechnol. 23 2005 1147 1157
40. B. Leyland-Jpnes Trastuzumab: hope and realities Lancet Oncol. 3 2002 137 144
41. S.T. Proulx, P. Luciani, S. Derzsi, M. Rinderknecht, V. Mumprecht, J.C. Leroux, and M. Detmar Quantitative imaging of lymphatic function with liposomal indocyanine green Cancer Res. 70 2010 7053 7062
42. N. Lozano, Z.S. Al-Ahmady, N.S. Beziere, V. Ntziachristos, and K. Kostarelos Monoclonal antibody-targeted PEGylated liposome-ICG encapsulating doxorubicin an a potential theranostic agent Int. J. Pharm. 482 2015 2 10
43. G.D. Lewis, I. Figari, B. Fendly, W.L. Wong, P. Carter, C. Gorman, and H.M. Shepard Differential responses of human tumor-cell lines to anti-p185(HER2) monoclonal-antibodies Cancer Immunol. Immunother. 37 1993 255 263